Alloy Therapeutics Acquires Spannerwerks

October 23, 2025

Alloy Therapeutics has acquired Seattle-based Spannerwerks, a drug development consulting firm, which will operate as a wholly owned subsidiary and continue serving clients under the Spannerwerks name. The deal expands Alloy's capabilities beyond discovery into preclinical and clinical development, with Spannerwerks CEO Dara Lockert joining Alloy's leadership team.

Buyers
Alloy Therapeutics Inc.
Targets
Spannerwerks, LLC
Location
Washington, United States
Transaction Type
Buyout

Explore More

Related Acquisitions

Track M&A activity that matters to you

Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.